Previous close | 3.3000 |
Open | 3.3000 |
Bid | 3.8000 |
Ask | 5.5000 |
Strike | 7.50 |
Expiry date | 2024-05-17 |
Day's range | 3.3000 - 3.3000 |
Contract range | N/A |
Volume | |
Open interest | 2 |
We can readily understand why investors are attracted to unprofitable companies. For example, although...
AC Immune SA ( NASDAQ:ACIU ) shareholders should be happy to see the share price up 17% in the last month. But over the...
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update ACI-24.060 ABATE Phase 2 trial to report Abeta-PET imaging results in Q2 and H2ACI-7104.056 VacSYn Phase 2 trial in Parkinson’s disease on track for interim data in H2ACI-24.060 for Alzheimer’s disease (AD) received FDA Fast Track designationACI-35.030 ReTain Phase 2b program in preclinical (pre-symptomatic) AD patients, initiated by collaboration partnerCash of CHF 103 million at year end, plus the CHF 15 million